rss
Arch Dis Child Fetal Neonatal Ed 2002;87:F11-F14 doi:10.1136/fn.87.1.F11
  • Symposium

Oxygen therapy for infants with chronic lung disease

  1. S Kotecha1,
  2. J Allen2
  1. 1Department of Child Health, University of Leicester, Leicester LE2 7LX, UK
  2. 2Division of Pulmonary Medicine and Cystic Fibrosis Center, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  1. Correspondence to:
    Dr Kotecha, Department of Child Health, University of Leicester, Leicester LE2 7LX, UK;
    sk43{at}le.ac.uk

    Abstract

    Supplemental oxygen is a safe and effective treatment for infants with established chronic lung disease who are not at risk of further progression of retinopathy of prematurity (ROP). Oxygen saturations of < 92% should be avoided and a target range of at least 94–96% aimed for. The saturation target range for very preterm infants at risk of developing ROP is more controversial, but the therapeutic index is probably considerably narrower.

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.